The Uromigos
Episodes
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials
23 Mar 2020
Contributed by Lukas
Dr. David Boulware discusses existing data and ongoing prophylaxis studies.
Episode 12: COVID-19 in Cancer Patients - The Seattle Experience
20 Mar 2020
Contributed by Lukas
A discussion with doctors from the Fred Hutchinson Cancer Center in Seattle about COVID-19.
Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer
16 Mar 2020
Contributed by Lukas
Chuck Drake and Doug Johnson discuss possible risk benefits of immune checkpoint inhibitors during the COVID-19 pandemic.
Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective
16 Mar 2020
Contributed by Lukas
Dena Battle (President, KCCure) asks key patient-focused questions about kidney cancer management during the COVID-19 pandemic.
Episode 9: COVID-19 and Cancer: An International Perspective
16 Mar 2020
Contributed by Lukas
Five members of the groups from Europe and North America discuss the current situation for cancer patients.
Episode 8: COVID-19 and Cancer Patients
13 Mar 2020
Contributed by Lukas
Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen.
Episode 7: The First Uromigos Prostate Cancer Podcast
27 Feb 2020
Contributed by Lukas
Silke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer.
Episode 6: Urothelial Cancer Highlights from ASCO GU 2020
26 Feb 2020
Contributed by Lukas
In this episode, Professor Tom Powles and Dr. Brian Rini talk to Dr. Kala Sridhar about key developments in urothelial cancer presented at ASCO GU 202...
Episode 5: Renal Highlights from ASCO GU 2020
24 Feb 2020
Contributed by Lukas
Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco.
Episode 4: Treatment Choices in Front Line Advanced Renal Cancer
11 Feb 2020
Contributed by Lukas
Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment opt...
Episode 3: Pembrolizumab in Non-Muscle Invasive Bladder Cancer
11 Feb 2020
Contributed by Lukas
Guests Dr. Arjun Balar and Professor Seth Lerner give an overview of the recent FDA approval of pembrolizumab in this indication to Professor Tom Powl...
Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer
11 Feb 2020
Contributed by Lukas
Matthew Galski and Petros Grivas engage in a discussion with Professor Tom Powles and Dr. Brian Rini about IMVIGOR130.
Episode 1: Introduction to Uromigos Podcasts
11 Feb 2020
Contributed by Lukas
Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them